CD44‐stimulated dendrite formation (‘spreading’) in activated B cells
Authors:
- P. W. KincadePKP. W. Kincade
- S. Partida‐SánchezSPS. Partida‐Sánchez
- R. M. E. ParkhouseRPR. M. E. Parkhouse
- 1 January 1997
- journal article
- Published by Wiley in Immunology
- Vol. 90 (1) , 147-153
Abstract
A rat monoclonal antibody (mAb) (NIM‐R8), insolubilized by binding to plastic plates, induced a rapid and extensive formation of dendrite processes (‘spreading’) in B lymphocytes activated by anti‐IgM and interleukin‐4 (IL‐4) or anti‐CD38 and IL‐4. In contrast, resting B cells were unable to spread similarly on the NIM‐R8‐coated plates. The NIM‐R8 antibody recognized a 90 000 MW surface glycoprotein (gp90) present on both B and T lymphocytes. The expression of this molecule was greatly increased after polyclonal (lipopolysaccarhide, anti‐IgM plus IL‐4 or concanavalin A) activation. The NIM‐R8 mAb with or without IL‐2 or IL‐4 was unable to induce proliferation of splenic lymphocytes. Following the demonstration that the NIM‐R8 mAb recognizes the murine equivalent of human CD44, the induction of spreading of activated B lymphocytes was studied using a panel of mAb recognizing different epitopes of murine CD44. All of these different mAb induced similar spreading of activated B cells. The ligand‐inducible spreading of activated B lymphocytes may be an important mechanism for providing an increased cell‐surface area for cell–cell or cell–matrix interactions, and thus may be an important factor controlling the response of activated lymphocytes.Keywords
This publication has 26 references indexed in Scilit:
- ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.Journal of Cell Biology, 1994
- Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.Journal of Experimental Medicine, 1994
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.Journal of Experimental Medicine, 1993
- Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.Journal of Cell Biology, 1992
- Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.Journal of Experimental Medicine, 1992
- Distinct effects of two CD44 isoforms on tumor growth in vivo.Journal of Experimental Medicine, 1991
- T and B cell collaboration: induction of motility in small, resting B cells by interleukin 4European Journal of Immunology, 1991
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.Journal of Experimental Medicine, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Preparation and characterisation of an antiserum to the mouse candidate for immunoglobulin DNature, 1976